(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

The weight-loss drugs market is set to grow to around Rs 5,000 crore in India by 2030, up from Rs 1,000 crore at present, ...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their tragic outcomes, a large new study found.

Overall, the research suggests that medications originally developed for diabetes and weight loss may also play a role in protecting the heart. By improving blood flow in the smallest vessels of the ...

A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment ...